[Iron supplementation in chronic kidney disease]

Abstract

Treatment with iron preparations remains one of the main directions in the treatment of anemia in patients with chronic kidney disease. Intravenous agents, although effective, may have serious adverse effects, while oral iron supplementation may be ineffective due to malabsorption and gastrointestinal side effects. The solution may be modern drugs such as ferric pyrophosphate added to dialysis fluid or liposomal iron without gastrointestinal adverse effects.

Keywords: anemia; chronic kidney disease; ferric pyrophosphate; ferritin; iron; liposomal iron; transferin.